483 related articles for article (PubMed ID: 22031815)
1. Antiviral activity and increased host defense against influenza infection elicited by the human cathelicidin LL-37.
Barlow PG; Svoboda P; Mackellar A; Nash AA; York IA; Pohl J; Davidson DJ; Donis RO
PLoS One; 2011; 6(10):e25333. PubMed ID: 22031815
[TBL] [Abstract][Full Text] [Related]
2. Human cathelicidin LL-37-derived peptide IG-19 confers protection in a murine model of collagen-induced arthritis.
Chow LN; Choi KY; Piyadasa H; Bossert M; Uzonna J; Klonisch T; Mookherjee N
Mol Immunol; 2014 Feb; 57(2):86-92. PubMed ID: 24091294
[TBL] [Abstract][Full Text] [Related]
3. Cathelicidins Have Direct Antiviral Activity against Respiratory Syncytial Virus In Vitro and Protective Function In Vivo in Mice and Humans.
Currie SM; Gwyer Findlay E; McFarlane AJ; Fitch PM; Böttcher B; Colegrave N; Paras A; Jozwik A; Chiu C; Schwarze J; Davidson DJ
J Immunol; 2016 Mar; 196(6):2699-710. PubMed ID: 26873992
[TBL] [Abstract][Full Text] [Related]
4. Cationic host defense peptides; novel antimicrobial therapeutics against Category A pathogens and emerging infections.
Findlay F; Proudfoot L; Stevens C; Barlow PG
Pathog Glob Health; 2016; 110(4-5):137-47. PubMed ID: 27315342
[TBL] [Abstract][Full Text] [Related]
5. Cathelicidins display conserved direct antiviral activity towards rhinovirus.
Sousa FH; Casanova V; Findlay F; Stevens C; Svoboda P; Pohl J; Proudfoot L; Barlow PG
Peptides; 2017 Sep; 95():76-83. PubMed ID: 28764966
[TBL] [Abstract][Full Text] [Related]
6. The human cathelicidin LL-37 inhibits influenza A viruses through a mechanism distinct from that of surfactant protein D or defensins.
Tripathi S; Tecle T; Verma A; Crouch E; White M; Hartshorn KL
J Gen Virol; 2013 Jan; 94(Pt 1):40-49. PubMed ID: 23052388
[TBL] [Abstract][Full Text] [Related]
7. Cathelicidin antimicrobial peptides suppress EV71 infection via regulating antiviral response and inhibiting viral binding.
Yu J; Dai Y; Fu Y; Wang K; Yang Y; Li M; Xu W; Wei L
Antiviral Res; 2021 Mar; 187():105021. PubMed ID: 33508330
[TBL] [Abstract][Full Text] [Related]
8. The human cathelicidin LL-37 has antiviral activity against respiratory syncytial virus.
Currie SM; Findlay EG; McHugh BJ; Mackellar A; Man T; Macmillan D; Wang H; Fitch PM; Schwarze J; Davidson DJ
PLoS One; 2013; 8(8):e73659. PubMed ID: 24023689
[TBL] [Abstract][Full Text] [Related]
9. Cathelicidin deficiency predisposes to eczema herpeticum.
Howell MD; Wollenberg A; Gallo RL; Flaig M; Streib JE; Wong C; Pavicic T; Boguniewicz M; Leung DY
J Allergy Clin Immunol; 2006 Apr; 117(4):836-41. PubMed ID: 16630942
[TBL] [Abstract][Full Text] [Related]
10. Antiviral Activity of the Human Cathelicidin, LL-37, and Derived Peptides on Seasonal and Pandemic Influenza A Viruses.
Tripathi S; Wang G; White M; Qi L; Taubenberger J; Hartshorn KL
PLoS One; 2015; 10(4):e0124706. PubMed ID: 25909853
[TBL] [Abstract][Full Text] [Related]
11. Cathelicidin host defence peptide augments clearance of pulmonary Pseudomonas aeruginosa infection by its influence on neutrophil function in vivo.
Beaumont PE; McHugh B; Gwyer Findlay E; Mackellar A; Mackenzie KJ; Gallo RL; Govan JR; Simpson AJ; Davidson DJ
PLoS One; 2014; 9(6):e99029. PubMed ID: 24887410
[TBL] [Abstract][Full Text] [Related]
12. Liu Shen Wan inhibits influenza a virus and excessive virus-induced inflammatory response via suppression of TLR4/NF-κB signaling pathway in vitro and in vivo.
Ma Q; Huang W; Zhao J; Yang Z
J Ethnopharmacol; 2020 Apr; 252():112584. PubMed ID: 31972325
[TBL] [Abstract][Full Text] [Related]
13. Leukotriene B4 induces release of antimicrobial peptides in lungs of virally infected mice.
Gaudreault E; Gosselin J
J Immunol; 2008 May; 180(9):6211-21. PubMed ID: 18424743
[TBL] [Abstract][Full Text] [Related]
14. Human cathelicidin peptide LL-37 as a therapeutic antiviral targeting Venezuelan equine encephalitis virus infections.
Ahmed A; Siman-Tov G; Keck F; Kortchak S; Bakovic A; Risner K; Lu TK; Bhalla N; de la Fuente-Nunez C; Narayanan A
Antiviral Res; 2019 Apr; 164():61-69. PubMed ID: 30738837
[TBL] [Abstract][Full Text] [Related]
15. Cathelicidin and Calprotectin Are Disparately Altered in Murine Models of Inflammatory Arthritis and Airway Inflammation.
Hemshekhar M; Piyadasa H; Mostafa D; Chow LNY; Halayko AJ; Mookherjee N
Front Immunol; 2020; 11():1932. PubMed ID: 32973796
[TBL] [Abstract][Full Text] [Related]
16. Endogenous cathelicidin is required for protection against ZIKV-caused testis damage via inactivating virons.
Liu Z; Wu J; Qin Z; Dong C; Yang H; Sun J; Xu W; Wei L
Antiviral Res; 2022 Feb; 198():105248. PubMed ID: 35038500
[TBL] [Abstract][Full Text] [Related]
17. Unique features of human cathelicidin LL-37.
Bandurska K; Berdowska A; Barczyńska-Felusiak R; Krupa P
Biofactors; 2015; 41(5):289-300. PubMed ID: 26434733
[TBL] [Abstract][Full Text] [Related]
18. In-vitro effect of human cathelicidin antimicrobial peptide LL-37 on dengue virus type 2.
Alagarasu K; Patil PS; Shil P; Seervi M; Kakade MB; Tillu H; Salunke A
Peptides; 2017 Jun; 92():23-30. PubMed ID: 28400226
[TBL] [Abstract][Full Text] [Related]
19. LL-37 restored glucocorticoid sensitivity impaired by virus dsRNA in lung.
Li K; Tao N; Zheng L; Sun T
Int Immunopharmacol; 2020 Feb; 79():106057. PubMed ID: 31877496
[TBL] [Abstract][Full Text] [Related]
20. Human cathelicidin, LL-37, inhibits respiratory syncytial virus infection in polarized airway epithelial cells.
Harcourt JL; McDonald M; Svoboda P; Pohl J; Tatti K; Haynes LM
BMC Res Notes; 2016 Jan; 9():11. PubMed ID: 26732674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
